Reliable, reproducible, and scalable 3D in vitro platforms for drug safety & efficacy testing | The Model of Excellence™
Zurich, Switzerland
- Tweets 946
- Following 386
- Followers 885
- Likes 710
InSphero is at HIRN 2025!
HIRN kicks off today in Bethesda, MD, and we’re excited to share our solutions for studying:
✔️ Islet function
✔️ β-cell regeneration & preservation
Chat with our experts and check out our posters on cutting-edge diabetes research. Let’s connect! 🧬
5
217
🎉 AASLD is just days away!
Join us to explore cutting-edge research on anti-fibrotic treatments for #MASH.
📌 Poster Presentations:
Dr. Sue Grepper - Nov 15, 1:00–2:00 pm
Dr. Francisco Verdeguer - Nov 17, 1:00–2:00 pm
1
2
77
🎶 It's summertime and the livin' is easy... 🎶 but fresh insights go with any weather, right?
#TBT to @HamiltonRobotic case study titled: “Enhancing Scalability and Quality of 3D In Vitro Cell Models Production through Automation”
Link to Case study in comments
1
2
44
"With #AIcontinuing to be incorporated into #drugdiscovery, I want to highlight how these models are indispensable building blocks”, says Dr. Jan Lichtenberg in his latest opinion piece for The Medicine Maker.
👇Read the full article by checking the link in the comments.
1
2
55
The MASH CALL Initiative – This September!
Gain insights on your compounds' effects on:
- Anti-steatosis
- Anti-fibrosis
- Safety profile
- Comparison to clinical candidates
👉 Learn more by clicking the link in the comments to read Dr. Francisco Verdeguer's latest blog post.
1
2
182
⭐️Exciting day for InSpheros ⭐️
We were honored to host our Scientific Advisory Board member, Prof. @MatthiasHerrath, VP Chief Medical Office at @novonordisk and Director of the Diabetes Research Institute @univmiami, at our office yesterday!
1
2
84
⭐️ Spotlight Series – HUMAIN Award Winners ⭐️
Meet Dr. @FeliciaGerst from the @uni_tue , with whom we discussed her winning project, and how InSphero’s assay-ready 3D InSight™ Human Islet Microtissues and Akura™ Twin OoC platforms enable her research
#TheModelofExcellence™
1
3
67
🌟 Second Day at EUROoCS! 🌟
Stop by booth 16 to learn more about our reliable, scalable, and reproducible #OoC and #LiverMicrotissues innovations.
Don't miss posters T-112 and T-098 today at 12:30.
We look forward to seeing you there! 👋
2
49
The @EUROoCS Annual Meeting has just started!
Our team collected our OoC platforms from the fashion streets of Milan and they are all ready to meet you at booth #16.
5
67
POV: Going to Milan for @euroocs 2024 😎 Sound ON 🔉
👉Stay tuned for our scientific lineup
#EUROoCS @pe_losk #MPS #organonchip #TheModelOfExcellence™
1
3
99
🔓 Are you ready to unlock the full potential of your cell culture research?
Meet us at #SLAS2023, 📍Booth #1003 where we will showcase our full portfolio of scalable 3D cell culture solutions for reproducible, uniform, and robust spheroids.
#3dcellculture #labautomation
5
432
The theme of #WorldDiabetesDay2022 is Access to #DiabetesCare.At #InSphero, we #RewriteTheStory by investigating and providing actionable solutions to increase understanding of diabetes disease pathogenesis, prevention and treatment. Learn more: lnkd.in/ewnErb3W
#WDD2022
1
3
The 43rd Annual Meeting of the American College of Toxicology @ACToxicology is less than a week away! If you are joining #ACTOX2022 in Denver, make sure to meet InSphero at Booth #827!
Book a meeting with our #liverdiscovery team: lnkd.in/eyyHHd2K
#toxicology
2
Here is a sneak peek on what our liver experts are presenting at the American Association for the Study of Liver Diseases (AASLD) Liver Meeting! @AASLDtweets
Book your meeting with our team: lnkd.in/ekmijXAj
#liverdisease #nash #3dcellculture #drugdiscovery #TLM22 #AASLD
ALT AASLD TLM22 - Meet InSphero's Liver Discovery Experts at Booth #415!
1
3
@Sagimet and @InSphero correctly predicted the reduction of liver fat of the clinical candidate TVB-2640 in 3D #liver #spheroids, showing now promising results in #NASH resolution in a #clinicaltrial
Read the publication: lnkd.in/euvGMC87
#liverdisease #drugdiscovery #ooc
ALT InSphero 3D models predict reduction of liver fat by Sagimet's FASN inhibitor for Non-alcoholic Steatohepatitis (NASH)
2
4
#BioJapan2022, the largest networking event for the #Biotech and #Pharma industries in #Japan, was a unique opportunity to explore diverse post-pandemic opportunities for our scalable portfolio and our service offerings in the Japanese market.
#organonachip #research
2
Did we mention that we have chocolates at booth #1728? Last chance to stop by, talk to our team and enjoy a delicious treat! #slas2022
1
It comes with great honor that we can announce our CEO and Co-Founder Jan Lichtenberg's appointment to the Board of Directors of the @SLAS_Org (Society for Laboratory Automation and Screening). Release: insphero.com/media-release/i…
4
Attending #SLAS2021? Check out the panel on #organononachip solutions at 1PM EST Jan 26 in the #SB12 SIG
linkedin.com/feed/update/urn…
#Highcontent #imagingsolutions #microfluidics #drugdiscovery #organnetworks #multitissuenetworks #3dcellculture
1
3